Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis
Completed · Phase 3
Conditions studied: Moderate to Severe Chronic Plaque-type Psoriasis
In brief
The purpose of this study is to assess secukinumab high dose (every 2 weeks) vs standard dose (every 4 weeks) in heavy body weight subjects with moderate to severe plaque psoriasis.
Key facts
- Study ID
- NCT03504852
- Run by
- Novartis Pharmaceuticals
- People needed
- 331
- Starts
- 2018-06-25
- Expected to finish
- 2020-07-15
- Last updated by the study team
- 2021-10-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Phoenix, Arizona, United States
- Novartis Investigative Site — Rogers, Arkansas, United States
- Novartis Investigative Site — Irvine, California, United States
- Novartis Investigative Site — Sacramento, California, United States
- Novartis Investigative Site — Sacramento, California, United States
- Novartis Investigative Site — San Diego, California, United States
- Novartis Investigative Site — Santa Monica, California, United States
- Novartis Investigative Site — Centennial, Colorado, United States
- Novartis Investigative Site — Tampa, Florida, United States
- Novartis Investigative Site — West Palm Beach, Florida, United States
- Novartis Investigative Site — Alpharetta, Georgia, United States
- Novartis Investigative Site — Snellville, Georgia, United States
- Novartis Investigative Site — Skokie, Illinois, United States
- Novartis Investigative Site — Indianapolis, Indiana, United States
- Novartis Investigative Site — New Albany, Indiana, United States
- Novartis Investigative Site — Louisville, Kentucky, United States
- Novartis Investigative Site — Owensboro, Kentucky, United States
- Novartis Investigative Site — Boston, Massachusetts, United States
- Novartis Investigative Site — New Brighton, Minnesota, United States
- Novartis Investigative Site — Saint Joseph, Missouri, United States
- Novartis Investigative Site — East Windsor, New Jersey, United States
- Novartis Investigative Site — Verona, New Jersey, United States
- Novartis Investigative Site — Forest Hills, New York, United States
- Novartis Investigative Site — New York, New York, United States
- Novartis Investigative Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.